Taking Combivent means you’re managing chronic lung disease. Life insurance can still protect your family, but you need to understand how underwriters evaluate COPD applicants. This guide covers realistic approval odds, how disease stage impacts rates, and what insurers actually assess.
Approval Likelihood
Rate Impact
Underwriting Timeline
Medical Testing
What Combivent Use Signals to Insurers
What It Signals
Combivent (Ipratropium Bromide/Albuterol) is a dual-action maintenance inhaler prescribed primarily for COPD (Chronic Obstructive Pulmonary Disease). Use signals that you have been diagnosed with chronic obstructive airway disease and require daily medication to manage breathing. This is a serious, progressive condition that limits airflow and oxygen delivery. COPD significantly impacts life expectancy and mortality risk—which is why insurers take it seriously. Unlike conditions like Type 2 diabetes that can be well-controlled indefinitely, COPD typically progresses over time, even with good management.
“COPD is a serious underwriting condition. Insurers recognize this is chronic lung disease with real mortality implications. Approval depends on disease stage—mild COPD can be insurable at moderate rates, but moderate or severe COPD dramatically limits options. The smoking history is equally important; current smokers face severe restrictions regardless of disease stage. Complete honesty about both disease severity and smoking is absolutely critical.”
– InsuranceBrokers USA – Management Team
COPD Stage Matters Enormously
Stage 1 (Mild) COPD with FEV1 80%+ is insurable. Stage 2 (Moderate) with FEV1 50-79% faces significant rate increases. Stage 3 (Severe) with FEV1 30-49% may be declinable or require specialized carriers. Stage 4 (Very Severe) with FEV1 under 30% is typically uninsurable through standard channels.
Smoking Status Is Critical
Current smokers with COPD face severe restrictions or outright denial from most carriers. Recent quitters (within 1-2 years) still face significant rate increases. Former smokers (3+ years quit) get substantially better underwriting. If you quit smoking specifically to apply for insurance, carriers verify this through medical records and may decline based on lack of stability.
Disease Management Stability Matters
Frequent exacerbations, emergency room visits, or hospitalizations in the past year signal poor control and reduce approval odds. Applicants with stable disease for over 12+ months fare better. Oxygen requirement level impacts underwriting—those requiring supplemental oxygen 24/7 face much higher restrictions than those who don’t.
How Underwriters Evaluate COPD
COPD underwriting goes far deeper than diabetes or most other conditions. Insurers need concrete data: pulmonary function test results, specifically the FEV1 (Forced Expiratory Volume in 1 second), which measures how much air you can forcibly exhale in one second. This single number drives most underwriting decisions. Insurers also examine smoking history in detail, exacerbation frequency, oxygen requirements, and comorbidities like heart disease or pneumonia history.
What Gets Evaluated
FEV1 Percentage (Lung Function)
This is the primary driver of approval and rates. FEV1 above 80% predicted is mild; 50-79% is moderate; 30-49% is severe; below 30% is very severe. Each category has dramatically different underwriting implications.
Smoking History (Current, Recent, Former)
Insurers distinguish sharply between current smokers, those who quit recently, and long-term former smokers. Any current smoking with COPD typically results in a decline or extreme rates. This is verified through medical records and may include nicotine screening.
Exacerbation Frequency (Attacks in Past Year)
More than one exacerbation per year signals unstable disease. Multiple exacerbations, emergency room visits, or hospitalizations within 12 months raise significant underwriting concerns about disease progression and future risk.
Oxygen Requirements (If Any)
Applicants requiring supplemental oxygen face substantially higher rates or possible decline. The more oxygen needed (continuous vs. as-needed), the worse the underwriting outcome. Oxygen requirement indicates advanced disease.
Comorbidities (Heart Disease, Pneumonia, etc.)
COPD frequently occurs alongside heart disease or other lung complications. Any additional health conditions complicate underwriting further and increase rates substantially.
Complete Disclosure: What Insurers Need to Know
This Is Critical
Incomplete or dishonest disclosure on COPD applications is a primary reason for denial and policy rescission. Insurers will obtain medical records, pulmonary function test reports, and smoking status verification. Any omissions or misstatements will be discovered. The consequence is not just denial—it can be policy cancellation after approval if dishonesty is uncovered, which means your family gets no benefit and premiums paid are forfeited.
What Must Be Disclosed
COPD Diagnosis Date and Current Stage
Report exactly when you were diagnosed and the current disease stage as documented by your pulmonologist. Do not guess or understate severity. Insurers compare your disclosure to actual medical records.
Most Recent FEV1 Test Result
Provide the exact percentage from your most recent pulmonary function test. This is a core underwriting document. Outdated FEV1 results trigger re-testing at the insurer’s expense, delaying approval.
Complete Smoking History
If current: disclose fully. If former: provide exact quit date and how long you smoked. Do not omit this or minimize it. Carriers verify smoking status through records and nicotine screening. Lying about smoking history is grounds for immediate denial or policy rescission.
Exacerbations and Hospitalizations (Past 12 Months)
Report all COPD-related emergency room visits, hospitalizations, or significant exacerbations in the past year. Provide dates. Underwriters verify this through medical records.
Oxygen Use (If Applicable)
If you use supplemental oxygen, disclose whether it’s continuous, at night only, or as-needed. Include the oxygen saturation level at which you require it. This is documented in medical records that insurers will obtain.
All Current COPD Medications
Beyond Combivent, disclose all other inhalers, corticosteroids, or medications you take for lung disease. Underwriters use a medication regimen to assess disease severity.
Getting Approved With COPD
Approval with COPD is possible, but it requires an honest assessment of your disease stage and realistic expectations. Mild COPD (Stage 1) with FEV1 above 80% and no significant smoking history has reasonable approval odds. Moderate COPD (Stage 2) is still insurable, but with higher rates and more carriers declining. Severe or very severe COPD (Stages 3-4) becomes very difficult—many carriers won’t touch it, and those that do charge extreme rates.
Best Case Scenario for Approval
Mild COPD, Long-Term Former Smoker, Stable Control
FEV1 above 80%, quit smoking 5+ years ago, no exacerbations in the past year, no oxygen requirement. This applicant has reasonable approval odds across most carriers at moderate rate premiums (25-50% higher than standard). This is the most favorable COPD profile for life insurance.
Difficult Scenarios
Current Smoker With COPD
Most mainstream carriers decline entirely. A few niche carriers might approve, but at extreme rates (100-200%+ increase). Quitting smoking before applying dramatically improves outcomes, but carriers need to see sustained cessation (typically 12+ months minimum).
Moderate to Severe COPD (FEV1 Below 50%)
Approval is possible but limited to specialty carriers, with rates typically 75-150%+ higher than standard. Disease stage and stability heavily impact availability. Multiple carriers may decline, requiring placement with high-risk specialists.
Frequent Exacerbations or Recent Hospitalizations
Multiple exacerbations or hospitalizations in the past 12 months signal unstable disease. Most carriers view this negatively. Waiting 6-12 months after your last exacerbation to demonstrate stability improves approval odds and rates substantially.
What You’ll Pay: Honest Pricing
” COPD typically results in 25-100%+ premium increases, sometimes higher. Disease stage is the primary driver, with smoking history a close second.”
InsuranceBrokers USA – Management Team
Realistic Pricing By Disease Stage
Stage 1 (Mild) COPD – FEV1 80%+
Rate increase: 25-50% above standard for non-smokers; 50-100%+ for recent former smokers. Example: A 55-year-old who would pay $75/month at standard rates might pay $95-115/month with mild COPD (non-smoker history).
Stage 2 (Moderate) COPD – FEV1 50-79%
Rate increase: 50-100%+ above standard. Example: The same applicant might pay $140-180/month. Fewer carriers offer coverage at this stage, limiting competition and options.
Stage 3+ (Severe) COPD – FEV1 Below 50%
Rate increase: 100-200%+ or possible decline. Very limited carrier options. Approval is uncertain; pricing is speculative. Some applicants at this stage cannot get approved through standard life insurance at any price.
Smoking Status Impact
Current smokers: Add 50-100% to any rate quoted for former smokers at the same disease stage. Recent quitters (1-3 years): Add 25-50%. Long-term former smokers (5+ years): Standard rate adjustment for disease stage only. This is substantial—quitting smoking before applying can cut your rates by half.
Application Strategy for Success
Before You Apply
Get Your Most Recent Pulmonary Function Test
If your last test is older than 6 months, see your pulmonologist for updated FEV1 results. Insurers will order new testing if yours are outdated, delaying approval. Having current results speeds up underwriting dramatically. Get a copy for your records.
If You Smoke: Quit Before Applying (or Be Honest)
Quitting 12+ months before applying significantly improves approval odds and rates. If you’re still smoking, disclose it—underwriters will verify, and dishonesty results in denial or rescission. There’s no benefit to hiding it.
Wait After Recent Exacerbations
If you had an exacerbation, ER visit, or hospitalization recently, waiting 6-12 months to apply demonstrates disease stability and improves underwriting. Applying immediately after an exacerbation signals poor control.
During Application
Provide All Documentation Upfront
Submit copies of your most recent pulmonary function test, medical records from your pulmonologist, and any ER or hospitalization records from the past year. Complete documentation speeds approval. Incomplete applications get held for requests, delaying decisions.
Be Thorough and Honest on the Application
Don’t skip questions or minimize answers. Report all COPD details, smoking history, medications, and hospitalizations. Carriers verify everything through medical records—omissions will be discovered and result in denial.
Expect and Cooperate With Medical Testing
Insurers will order pulmonary function testing, blood work, and possibly chest X-rays. Schedule these promptly and have results sent to the insurance company. Delays in testing delay approval. Testing is standard and required for accurate underwriting.
If You’re Declined
Ask Why and What Might Change
Request a detailed decline reason from the insurer. Common reasons: FEV1 too low, current smoking, recent exacerbations. If the reason is modifiable (recent exacerbations, recent quitting), waiting 6-12 months and reapplying may result in approval.
Try Specialty COPD Carriers
Some carriers specialize in COPD and higher-risk cases. If declined by mainstream carriers, these specialists may approve at higher rates. Working with a broker familiar with COPD cases is critical for accessing these options.
Common Questions: Answered
Will I definitely be declined because I have COPD?
Direct answer: No, but approval depends heavily on disease stage and smoking history.
Mild COPD with a non-smoking or long-term former smoking history has reasonable approval odds. Moderate COPD is still possible, but with fewer carriers. Severe COPD makes approval difficult. Current smoking with any COPD stage severely limits options. Stage and smoking history are the primary approval drivers.
How much will my rates increase because of COPD?
Direct answer: Substantially—typically 25-100% or more, depending on disease stage and smoking history.
Mild COPD with no smoking history: 25-50% increase. Moderate COPD: 50-100%+ increase. Severe COPD: 100-200%+ or possible decline. Current smoking adds 50-100% on top. This is realistic—COPD is a serious lung disease with real mortality implications.
Does my FEV1 number really determine everything?
Direct answer: Yes, largely. FEV1 is the single most important underwriting factor for COPD applicants.
FEV1 above 80% (Mild): Reasonable approval odds. FEV1 50-79% (Moderate): More difficult but possible. FEV1 below 50% (Severe): Limited options. Even small FEV1 differences significantly impact approval and rates. If your FEV1 is borderline, even modest improvement can meaningfully improve your underwriting.
Can I hide my smoking history?
Direct answer: No. Do not attempt this—it results in denial or policy rescission.
Insurers verify smoking through medical records and nicotine screening tests. Omitting or misrepresenting smoking history is application fraud and grounds for immediate denial or policy cancellation after approval, meaning your family gets no benefit. Complete honesty is always the safest approach, even if rates are higher for smokers.
How long does underwriting take with COPD?
Direct answer: Typically 4-6 weeks. Can extend to 8+ weeks if pulmonary testing is needed or medical records are incomplete.
Straightforward cases with recent FEV1 results and complete documentation move faster. Cases requiring new pulmonary function testing take longer—testing typically takes 2-3 weeks to schedule and complete. Providing all documentation upfront significantly speeds the process.
Will I need medical testing?
Direct answer: Yes, almost certainly. COPD applicants routinely need pulmonary function testing.
Most insurers order pulmonary function tests (FEV1), blood work, and sometimes chest X-rays. The insurer may order these or use recent results from your physician if they’re current. Testing is standard and required for accurate underwriting of COPD applicants. If your results are less than 6 months old, the insurer may accept them instead of ordering new testing.
What if I’m using oxygen—am I uninsurable?
Direct answer: Oxygen use complicates underwriting significantly, but you’re not automatically uninsurable.
Continuous oxygen use signals advanced COPD and results in substantial rate increases or possible decline from mainstream carriers. Nighttime-only or as-needed oxygen use is less severe. Specialty carriers may approve oxygen-dependent applicants at very high rates. Approval is possible but limited and expensive—this represents severe disease.
Will my insurance rates change after I get the policy?
Direct answer: No. Once approved and in force, your premiums remain locked in regardless of disease progression.
Any future changes to your COPD—FEV1 decline, increased oxygen needs, exacerbations—will not affect your rates or coverage under a level-premium term policy or whole life policy. Your rates stay the same for the life of your policy. This is why locking in coverage now, even at higher rates, can be valuable.
What if I had a recent exacerbation—should I apply now or wait?
Direct answer: Waiting 6-12 months typically produces better approval odds and rates.
Recent exacerbations, ER visits, or hospitalizations signal unstable disease and result in declined applications or very high rates. Waiting several months to demonstrate stability dramatically improves underwriting. If you had a major exacerbation recently, the strategic approach is usually to wait, then apply once you’ve gone 6-12 months without another episode.
Life Insurance With COPD Is Possible
COPD makes life insurance more difficult and expensive, but not impossible. Mild to moderate disease with honest disclosure and good disease management can result in approval at rates you can afford. The key is complete honesty about your condition, disease stage, and smoking history—omitting or minimizing these will result in denial.
Call Now: 888-211-6171
Licensed agents with experience underwriting COPD applicants. We help you find carriers that will approve your application and explain what to expect.
Disclaimer: This information is for educational purposes and does not constitute legal, medical, or insurance advice. Life insurance availability and pricing for applicants with COPD vary by individual circumstances, insurance company, state regulations, and disease stage. Approval rates and pricing referenced are based on common underwriting practices for COPD applicants. FEV1 targets and COPD staging are based on medical standards (GOLD guidelines) as of the publication date. Specific underwriting decisions depend on comprehensive evaluation of individual health status, disease stage, smoking history, medical history, and insurance company guidelines. If you have concerns about your COPD diagnosis or treatment, consult with your pulmonologist or healthcare provider.
